Antibody Engineering & Therapeutics US 2026

Biointron is pleased to announce our participation in Antibody Engineering & Therapeutics US (AET US) 2026, the premier antibody and protein engineering conference. The event is scheduled for December 13 - 16, 2026, at the Marriott Marquis San Diego, California, bringing together scientists and industry experts focused on accelerating biologic discovery toward therapeutic impact.  

AET US is widely recognized as a central forum for cutting-edge research across antibody engineering, protein therapeutics, and related technologies. The program features a broad range of scientific presentations, interactive discussions, and networking sessions that delve into topics such as multispecifics, ADCs, advanced discovery methods, and engineering strategies for next-generation biologics.  

Biointron will join leading innovators at the conference to connect with peers, exchange insights, and highlight our advancements in high-throughput antibody discovery and engineering. This event provides a valuable opportunity to explore emerging trends in protein design and therapeutic optimization alongside global thought leaders. 

Biointron looks forward to engaging with colleagues and partners in San Diego this December at Antibody Engineering & Therapeutics US 2026. 

For more details about the event, please visit the Antibody Engineering & Therapeutics US 2026 website [https://informaconnect.com/antibody-engineering-therapeutics/] 

Time: December 13 - 16, 2026 

Location: Marriott Marquis | San Diego, CA 

Booth: TBD